342 related articles for article (PubMed ID: 25342855)
1. Outcomes of everolimus-eluting stent incomplete stent apposition: a serial optical coherence tomography analysis.
Shimamura K; Kubo T; Akasaka T; Kozuma K; Kimura K; Kawamura M; Sumiyoshi T; Ino Y; Yoshiyama M; Sonoda S; Igarashi K; Miyazawa A; Uzui H; Sakanoue Y; Shinke T; Morino Y; Tanabe K; Kadota K; Kimura T
Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):23-8. PubMed ID: 25342855
[TBL] [Abstract][Full Text] [Related]
2. Fate of post-procedural malapposition of everolimus-eluting polymeric bioresorbable scaffold and everolimus-eluting cobalt chromium metallic stent in human coronary arteries: sequential assessment with optical coherence tomography in ABSORB Japan trial.
Sotomi Y; Onuma Y; Dijkstra J; Miyazaki Y; Kozuma K; Tanabe K; Popma JJ; de Winter RJ; Serruys PW; Kimura T
Eur Heart J Cardiovasc Imaging; 2018 Jan; 19(1):59-66. PubMed ID: 28158421
[TBL] [Abstract][Full Text] [Related]
3. Optical coherence tomography evaluation of late strut coverage patterns between first-generation drug-eluting stents and everolimus-eluting stent.
Toledano Delgado FJ; Alvarez-Ossorio MP; de Lezo Cruz-Conde JS; Bellido FM; Romero Moreno MÁ; Fernández-Aceytuno AM; de Lezo Herrerosde Tejada JS; Pineda SO; Saint-Gerons JM; Pavlovic D
Catheter Cardiovasc Interv; 2014 Nov; 84(5):720-6. PubMed ID: 24174291
[TBL] [Abstract][Full Text] [Related]
4. Serial randomized comparison of strut coverage of everolimus- and first-generation sirolimus-eluting stents.
Kim JS; Kim JH; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Can J Cardiol; 2015 Jun; 31(6):723-30. PubMed ID: 25882337
[TBL] [Abstract][Full Text] [Related]
5. Comparison of neointimal coverage between everolimus-eluting stents and sirolimus-eluting stents: an optical coherence tomography substudy of the RESET (Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial).
Kubo T; Akasaka T; Kozuma K; Kimura K; Kawamura M; Sumiyoshi T; Ino Y; Morino Y; Tanabe K; Kadota K; Kimura T;
EuroIntervention; 2015 Sep; 11(5):564-71. PubMed ID: 26390517
[TBL] [Abstract][Full Text] [Related]
6. Difference of neointimal growth patterns in bifurcation lesions among four kinds of drug-eluting stents: an optical coherence tomographic study.
Yoshimura T; Tanaka A; Mori N; Nakamura D; Taniike M; Makino N; Egami Y; Shutta R; Tanouchi J; Nishino M
Catheter Cardiovasc Interv; 2014 Nov; 84(5):742-9. PubMed ID: 24497273
[TBL] [Abstract][Full Text] [Related]
7. Serial optical coherence tomography assessment of malapposed struts after everolimus-eluting stent implantation. A subanalysis from the HEAL-EES study.
Ishida K; Otsuki S; Giacchi G; Ortega-Paz L; Shiratori Y; Freixa X; Martín-Yuste V; Masotti M; Sabaté M; Brugaletta S
Cardiovasc Revasc Med; 2017; 18(1):47-52. PubMed ID: 27634493
[TBL] [Abstract][Full Text] [Related]
8. Temporal changes of incomplete stent apposition during early phase after everolimus-eluting stent implantation: serial optical coherence tomography analyses at 2-week and 4-month.
Wakabayashi H; Ando H; Nakano Y; Takashima H; Waseda K; Shimoda M; Ohashi H; Suzuki A; Sakurai S; Amano T
Int J Cardiovasc Imaging; 2021 Feb; 37(2):411-417. PubMed ID: 32926310
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of limus-eluting stents and balloon angioplasty for sirolimus-eluting in-stent restenosis.
Ota H; Mahmoudi M; Kitabata H; Torguson R; Chen F; Satler LF; Suddath WO; Pichard AD; Waksman R
Cardiovasc Revasc Med; 2015 Mar; 16(2):84-9. PubMed ID: 25870152
[TBL] [Abstract][Full Text] [Related]
10. Cut-off value of strut-vessel distance for the resolution of acute incomplete stent apposition in the early phase using serial optical coherence tomography after cobalt-chromium everolimus-eluting stent implantation.
Oda H; Itoh T; Sasaki W; Uchimura Y; Taguchi Y; Kaneko K; Sakamoto T; Goto I; Sakuma M; Ishida M; Kikuchi T; Terashita D; Otake H; Morino Y; Shinke T
J Cardiol; 2020 Jun; 75(6):641-647. PubMed ID: 31924410
[TBL] [Abstract][Full Text] [Related]
11. Favorable neointimal coverage in everolimus-eluting stent at 9 months after stent implantation: comparison with sirolimus-eluting stent using optical coherence tomography.
Choi HH; Kim JS; Yoon DH; Hong KS; Kim TH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Int J Cardiovasc Imaging; 2012 Mar; 28(3):491-7. PubMed ID: 21442265
[TBL] [Abstract][Full Text] [Related]
12. Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: results of the randomized BIOFLOW-II trial.
Windecker S; Haude M; Neumann FJ; Stangl K; Witzenbichler B; Slagboom T; Sabaté M; Goicolea J; Barragan P; Cook S; Piot C; Richardt G; Merkely B; Schneider H; Bilger J; Erne P; Waksman R; Zaugg S; Jüni P; Lefèvre T
Circ Cardiovasc Interv; 2015 Feb; 8(2):e001441. PubMed ID: 25634905
[TBL] [Abstract][Full Text] [Related]
13. Vascular response to bioresorbable polymer sirolimus-eluting stent vs. permanent polymer everolimus-eluting stent at 9-month follow-up: an optical coherence tomography sub-study from the CENTURY II trial.
Kuramitsu S; Kazuno Y; Sonoda S; Domei T; Jinnouchi H; Yamaji K; Soga Y; Shirai S; Ando K; Saito S
Eur Heart J Cardiovasc Imaging; 2016 Jan; 17(1):34-40. PubMed ID: 26333375
[TBL] [Abstract][Full Text] [Related]
14. Comparison of neointimal coverage and extra-stent lumen between sirolimus and everolimus-eluting stent using optical coherence tomography.
Oda T; Okamura T; Yamada J; Miyagi N; Uehara H; Nao T; Tateishi H; Maeda T; Nakamura T; Shiraishi K; Nakashima T; Nishimura S; Miura T; Matsuzaki M; Yano M
Heart Vessels; 2016 Apr; 31(4):449-56. PubMed ID: 25614415
[TBL] [Abstract][Full Text] [Related]
15. Comparison of everolimus-eluting and sirolimus-eluting coronary stents: 1-year outcomes from the Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting stent Trial (RESET).
Kimura T; Morimoto T; Natsuaki M; Shiomi H; Igarashi K; Kadota K; Tanabe K; Morino Y; Akasaka T; Takatsu Y; Nishikawa H; Yamamoto Y; Nakagawa Y; Hayashi Y; Iwabuchi M; Umeda H; Kawai K; Okada H; Kimura K; Simonton CA; Kozuma K;
Circulation; 2012 Sep; 126(10):1225-36. PubMed ID: 22824435
[TBL] [Abstract][Full Text] [Related]
16. Comparison of early strut coverage between zotarolimus- and everolimus-eluting stents using optical coherence tomography.
Kim S; Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Cho YK; Nam CW; Hur SH; Jang Y; Hong MK
Am J Cardiol; 2013 Jan; 111(1):1-5. PubMed ID: 23040589
[TBL] [Abstract][Full Text] [Related]
17. Difference in vascular response between sirolimus-eluting- and everolimus-eluting stents in ostial left circumflex artery after unprotected left main as observed by optical coherence tomography.
Fujino Y; Attizzani GF; Tahara S; Naganuma T; Takagi K; Yabushita H; Wang W; Tanaka K; Matsumoto T; Kawamoto H; Yamada Y; Amano S; Watanabe Y; Warisawa T; Sato T; Mitomo S; Kurita N; Ishiguro H; Hozawa K; Tsukahara T; Motosuke M; Bezerra HG; Nakamura S; Nakamura S
Int J Cardiol; 2017 Mar; 230():284-292. PubMed ID: 28065691
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of Late-Acquired Incomplete Stent Apposition: A Comparison With First-Generation and Second-Generation Drug-Eluting Stents.
Waseda K; Ako J; Kume T; Fitzgerald PJ; Honda Y
J Invasive Cardiol; 2016 Aug; 28(8):323-9. PubMed ID: 26689416
[TBL] [Abstract][Full Text] [Related]
19. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms, pathophysiology, and clinical aspects of incomplete stent apposition.
Attizzani GF; Capodanno D; Ohno Y; Tamburino C
J Am Coll Cardiol; 2014 Apr; 63(14):1355-67. PubMed ID: 24530675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]